KLA is in a clear intermediate downtrend despite still-positive long-term performance: the stock is up 25.63% over the past year but has fallen 30.83% over three months and 22.49% over the past month, with the current price of $145.61 sitting at just 19.4% of its 52-week range (low $107.20, high $307.37). That positioning — closer to the lows than the highs after a halving from the peak (max drawdown -51.74%) — signals a falling-knife dynamic rather than a healthy consolidation, even though the 1-year return remains positive. The 14.25% YTD gain has been almost entirely erased by the recent slide, leaving the stock at a critical inflection where long-term holders are underwater on recent purchases.

Short-term momentum is decisively negative and accelerating: the 1-month change of -22.49% is worse than the 3-month change of -30.83% would imply on a run-rate basis, and the 6-month change of -24.75% confirms a sustained deterioration rather than a brief dip. Relative strength tells the same story — KLAC has underperformed the S&P 500 by 21.47 percentage points over one month and 33.68 points over three months (versus SPY's -1.02% and +2.85%, respectively), a violent divergence from its still-positive 12.50-point 1-year relative outperformance. The most recent sessions show capitulation-style selling (from $206.89 on October 2 to $145.61 on October 23, including a -9.5% single-day drop on October 22), with volume of 10.46 million shares suggesting heavy distribution; RSI is not provided but the price action is consistent with oversold conditions that may invite tactical bounces without reversing the trend.

Key technical levels are well defined: support sits at the 52-week low of $107.20, roughly 26% below the current price, while resistance begins at the $200 round-number area (the October breakdown zone) and extends to the $307.37 52-week high. A breakdown below the recent $145-$147 area would open the door to the $107 low and signal that the cyclical de-rating is deepening; a reclaim of $200 would be the first evidence of trend repair. With a beta of 1.447, KLAC is roughly 45% more volatile than the market, meaning position sizing should account for amplified drawdowns — the -51.74% peak-to-trough decline is a live reminder that this name can halve in a downturn, and the elevated short ratio of 2.58 days-to-cover adds potential for sharp squeezes on any positive catalyst.

Revenue is growing at a healthy clip but decelerating at the margin: the most recent quarter (ended June 30, 2026) delivered $3.658 billion in revenue, up 15.21% year-over-year, building on a multi-quarter progression from $3.210 billion (Q1 FY26) to $3.297 billion (Q2) to $3.415 billion (Q3) to $3.658 billion (Q4). Sequentially, growth has been steady at roughly 3-7% per quarter, and the segment mix shows the core Defect Inspection business at $3.521 billion and Service at $1.595 billion as the largest contributors, with Patterning at $1.343 billion — a portfolio heavily levered to leading-edge logic and memory inspection intensity. The 15% YoY growth is solid but well below the hyper-growth phase implied by the stock's earlier multiple, which helps explain why the market has re-rated the shares even as absolute revenue hits records.

Profitability is elite and stable: Q4 net income was $1.363 billion on a 37.27% net margin, with gross margin of 61.36% and operating margin of 42.49% — margins that have held in a tight 61.1%-61.9% gross range and 41.2%-42.5% operating range across the last four quarters. Net income has climbed from $1.121 billion (Q1) to $1.201 billion (Q3) to $1.363 billion (Q4), and the 35.57% trailing net margin and 41.69% operating margin place KLA among the most profitable companies in the semiconductor equipment industry, where 45-55% gross margins are more typical. The consistency of these margins through a volatile demand environment underscores the pricing power inherent in its process-control monopoly position.

Financial health is strong but not pristine: debt-to-equity stands at 0.97, the current ratio is a healthy 2.88, and TTM free cash flow is $3.767 billion, though quarterly FCF has been uneven ($817 million in Q4 versus $1.262 billion in Q2) due to working-capital swings. ROE of 76.08% and ROA of 20.80% reflect both genuine profitability and a leveraged balance sheet (equity multiplier ~2.83x), while interest coverage of roughly 21x provides ample cushion. The company returns massive capital — $571 million in buybacks and $305 million in dividends in Q4 alone — funded entirely from operations, with capex a modest $89 million, confirming that KLA generates more than enough cash to self-fund growth and shareholder returns without external financing.